HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix metalloproteinases as targets for the immune system during experimental arthritis.

Abstract
Novel therapies for rheumatoid arthritis aiming at intervention in the inflammatory process by manipulation of autoreactive T and B lymphocytes receive major interest. However, the development of such therapies is largely hampered by the lack of knowledge of self-Ags recognized during the disease process. Recently, we predicted putative T cell self-epitopes based on a computer search profile. In the present study, the predicted self-epitopes were tested for T cell recognition in two experimental arthritis models, and their arthritogenic capacity was analyzed. Fourteen of n = 51 predicted self-epitopes were recognized during experimental arthritis of which six were able to actively induce arthritis. Interestingly, three of these six peptides were derived from matrix metalloproteinases (MMP), and only T cells responsive to MMP-derived epitopes were able to passively transfer arthritis to naive rats. Moreover, we demonstrate the presence of Abs to MMP-3 during the course of adjuvant arthritis. Together these data indicate that MMPs play a pivotal role as target for T and B cells during the development of inflammatory arthritis. This finding sheds new light on the pathophysiological role of MMPs during arthritis and opens novel possibilities for Ag-specific immunotherapy.
AuthorsJolanda H M van Bilsen, Josée P A Wagenaar-Hilbers, Mayken C J T Grosfeld-Stulemeijer, Maarten J F van der Cammen, Mariska E A van Dijk, Willem van Eden, Marca H M Wauben
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 172 Issue 8 Pg. 5063-8 (Apr 15 2004) ISSN: 0022-1767 [Print] United States
PMID15067089 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Adjuvants, Immunologic
  • Autoantibodies
  • Autoantigens
  • Diamines
  • Epitopes, T-Lymphocyte
  • Histocompatibility Antigens Class II
  • Peptide Fragments
  • Quaternary Ammonium Compounds
  • dimethyldioctadecylammonium
  • Matrix Metalloproteinases
  • Matrix Metalloproteinase 3
  • avridine
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Adoptive Transfer
  • Animals
  • Arthritis, Experimental (enzymology, immunology, pathology)
  • Autoantibodies (biosynthesis)
  • Autoantigens (administration & dosage, immunology, metabolism)
  • B-Lymphocyte Subsets (immunology, metabolism)
  • CD4-Positive T-Lymphocytes (immunology, transplantation)
  • Cartilage, Articular (enzymology, immunology)
  • Diamines (administration & dosage)
  • Epitopes, T-Lymphocyte (administration & dosage, immunology, metabolism)
  • Histocompatibility Antigens Class II (metabolism)
  • Humans
  • Immune System (enzymology)
  • Lymph Nodes (enzymology, immunology)
  • Matrix Metalloproteinase 3 (administration & dosage, immunology)
  • Matrix Metalloproteinases (administration & dosage, immunology, metabolism)
  • Peptide Fragments (administration & dosage, immunology, metabolism)
  • Protein Binding (immunology)
  • Quaternary Ammonium Compounds (administration & dosage)
  • Rats
  • Rats, Inbred Lew
  • Spleen (enzymology, immunology)
  • T-Lymphocyte Subsets (immunology, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: